Literature DB >> 10426225

Endovascular treatment of cerebral vasospasm: assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography.

B Schuknecht1, J Fandino, C Yüksel, Y Yonekawa, A Valavanis.   

Abstract

In a retrospective study of 30 consecutive patients with symptomatic vasospasm the mean degree of narrowing as compared to the initial angiogram was 35% (+/- 24%) in 12 intradural internal carotid arteries (ICA), 42% (+/- 17%) in 42 proximal middle cerebral (MCA) and 38% (+/- 19%) in 27 anterior cerebral arteries (ACA). The corresponding increase in mean flow velocities from baseline values obtained by transcranial colour Doppler sonography (TCD) within 12 h of the first angiogram to the time of clinical vasospasm was considerably higher, with 49% (+/- 34%) in the ICA 119% (+/- 92%) in the MCA and 147% (+/- 170%) in the ACA. Following superselective intra-arterial papaverine application in 66 arteries and balloon angioplasty of 15 arteries, 78 (96.3%) of 81 dilated. Sustained clinical improvement was achieved in 22 patients (73.3%). The mean reversal of angiographic vasospasm was 71% for the ICA (range 10-100%), 81% for the MCA (range 9-100%) and 82% (range 0-100%) for the A1 segment. The mean reduction of flow velocities after treatment was much less with 23% (+/- 21%) in the ICA, 32% (+/- 24%) in the MCA and 25% (+/- 22%) in the A1 segment.

Entities:  

Mesh:

Year:  1999        PMID: 10426225     DOI: 10.1007/s002340050784

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

1.  Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen.

Authors:  Michael F Stiefel; Alejandro M Spiotta; Joshua D Udoetuk; Eileen Maloney-Wilensky; John B Weigele; Robert W Hurst; Peter D LeRoux
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Anterior cerebral artery angioplasty for intracranial atherosclerosis.

Authors:  Nazli Janjua; Afshin A Divani; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2008-01

3.  Vasospasm and delayed consequences.

Authors:  S Bracard; E Schmitt
Journal:  Interv Neuroradiol       Date:  2008-10-09       Impact factor: 1.610

4.  Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain.

Authors:  Mansi Krishan; Gary A Gudelsky; Pankaj B Desai; Mary Beth Genter
Journal:  Drug Deliv       Date:  2013-10-14       Impact factor: 6.419

5.  Initial experience of transcranial contrast-enhanced ultrasonography with Sonazoid in the evaluation of microvascular brain anatomy.

Authors:  Kozue Saito; Toshiko Hirai; Hajime Ohishi; Satoshi Ueno
Journal:  J Med Ultrason (2001)       Date:  2009-07-31       Impact factor: 1.314

6.  Continuous intra-arterial infusion of nimodipine during embolization of cerebral aneurysms associated with vasospasm.

Authors:  I Oran; C Cinar
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

7.  Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results.

Authors:  Alessandra Biondi; Giuseppe K Ricciardi; Louis Puybasset; Lamine Abdennour; Marcello Longo; Jacques Chiras; Rémy Van Effenterre
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

8.  Intraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Jong Hoon Kim; In Sung Park; Kyung Bum Park; Dong-Ho Kang; Soo Hyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30

9.  Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note.

Authors:  Johannes Platz; Krisztina Baráth; Emanuela Keller; Anton Valavanis
Journal:  Neuroradiology       Date:  2008-09-13       Impact factor: 2.804

10.  Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion.

Authors:  D Hänggi; B Turowski; K Beseoglu; M Yong; H J Steiger
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-27       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.